ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting

PURPOSE: The purpose of this study was to identify the excision repair cross-complementation group 1 (ERCC1) as a predictive marker for FOLFOX adjuvant chemotherapy in stages II and III colon cancer patients. METHODS: A total of 166 high risk stages II and III colon cancer patients were retrospectiv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Coloproctol
Hlavní autoři: Kim, Chee Young, Seo, Sang Hyuk, An, Min Sung, Kim, Kwang Hee, Bae, Ki Beom, Hwang, Jin Won, Kim, Ji Hyun, Kim, Bo Mi, Kang, Mi Seon, Oh, Min Kyung, Hong, Kwan Hee
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Coloproctology 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496459/
https://ncbi.nlm.nih.gov/pubmed/26161376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/ac.2015.31.3.92
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky